Acurx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	34	53	46	44	-
Market Cap Growth	-4.11%	14.29%	4.51%	-	-
Enterprise Value	25	45	37	31	-3
PE Ratio	-	-3.62	-3.81	-3.46	-
PB Ratio	5.70	11.30	6.31	3.56	-
P/FCF Ratio	-3.53	-5.38	-6.12	-8.81	-
P/OCF Ratio	-3.53	-5.38	-6.12	-8.81	-
EV/EBITDA Ratio	-1.85	-3.10	-3.06	-2.45	0.68
EV/EBIT Ratio	-1.85	-3.10	-3.06	-2.45	0.68
EV/FCF Ratio	-2.72	-4.62	-4.91	-6.22	0.93
Debt / Equity Ratio	-	-	-	-	0.02
Debt / EBITDA Ratio	-	-	-	-	-0.01
Debt / FCF Ratio	-	-	-	-	-0.02
Quick Ratio	2.87	2.50	4.42	15.36	6.72
Current Ratio	2.93	2.53	4.55	15.71	6.82
Return on Equity (ROE)	-308.50%	-289.70%	-132.30%	-114.10%	-261.30%
Return on Assets (ROA)	-193.30%	-185.20%	-118.30%	-104.80%	-159.80%
Return on Capital (ROIC)	-267.61%	-312.38%	-165.31%	-103.26%	-166.18%
Earnings Yield	-46.97%	-27.65%	-26.21%	-28.88%	-
FCF Yield	-31.98%	-18.59%	-16.35%	-11.36%	-
Buyback Yield / Dilution	-32.93%	-17.15%	-26.72%	-37.88%	-
Total Shareholder Return	-32.93%	-17.15%	-26.72%	-37.88%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).